Verastem (VSTM) Return on Capital Employed (QoQ) (2012 - 2026)

Verastem (VSTM) Return on Capital Employed (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2,173.00
Dec 31, 2025 427.00
Sep 30, 2025 1,146.00
Jun 30, 2025 2,403.00
Mar 31, 2025 -2,329.00
Dec 31, 2024 699.00
Sep 30, 2024 -2,833.00
Jun 30, 2024 -2,547.00
Mar 31, 2024 -2,428.00
Dec 31, 2023 -1,886.00
Sep 30, 2023 617.00
Jun 30, 2023 3,322.00
Mar 31, 2023 163.00
Dec 31, 2022 -304.00
Sep 30, 2022 -747.00
Jun 30, 2022 -1,178.00
Mar 31, 2022 -31.00
Dec 31, 2021 -790.00
Sep 30, 2021 -3,206.00
Jun 30, 2021 72.00